Drug Shortage Report for TOBRADEX

Last updated on 2017-11-02 History
Report ID 22359
Drug Identification Number 00778915
Brand name TOBRADEX
Common or Proper name TOBRADEX OINTMENT 3.5G
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE TOBRAMYCIN
Strength(s) 0.1% 0.3%
Dosage form(s) OINTMENT
Route of administration OPHTHALMIC
Packaging size 3.5g
ATC code S01CA
ATC description ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-09-14
Estimated end date 2017-10-25
Actual end date 2017-10-26
Shortage status Resolved
Updated date 2017-11-02
Company comments
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2017-11-02 French Compare
v7 2017-11-02 English Compare
v6 2017-10-18 French Compare
v5 2017-10-18 English Compare
v4 2017-09-26 French Compare
v3 2017-09-26 English Compare
v2 2017-09-18 French Compare
v1 2017-09-18 English Compare